Annals of Surgical Oncology adds new society affiliation

February 10, 2010

The Annals of Surgical Oncology (ASO), the official journal of the Society of Surgical Oncology, has announced an additional society affiliation with the American Society of Breast Surgeons beginning in 2010. Published by Springer, the ASO is a leading monthly publication that features original articles on the latest advances in oncology for surgeons from all specialties.

Dr. William Curtis, Executive Vice President for Clinical Medicine Publishing at Springer, said, "Springer is pleased to support the mission of the Society of Surgical Oncology through this exciting new partnership with the American Society of Breast Surgeons. Not only will the Annals of Surgical Oncology reach an important community of physicians, the journal will provide a high-value forum for the publication of the organization's research."

Dr. Arthur G. Lerner, Executive Vice President of the American Society of Breast Surgeons, said, "The American Society of Breast Surgeons welcomes the affiliation with the Annals of Surgical Oncology, ensuring the publication and dissemination of our organization's content in the highest ranked journal in the field of surgical oncology."

The Annals of Surgical Oncology is published at Springer electronically and in print. The journal includes Online First™, Cross Reference Linking, and Alert services. All authors, via the Springer Open Choice™ program, have the option of publishing their articles using the open access publishing model. Dr. Charles M. Balch of Johns Hopkins Medical Institutions is the editor-in-chief.

Dr. Fabrizio Michelassi, President of the Society of Surgical Oncology, emphasized the positive impact this arrangement has for the specialty of surgical oncology as a whole. "The Society of Surgical Oncology and the ASO have strategized to be the scientific and educational resource for all surgeons who treat cancer patients, regardless of geographic location or scope of practice. Having two important societies use the Annals of Surgical Oncology as their official journal establishes a partnership that benefits the entire surgical community and our patients."
-end-
Springer (www.springer.com) is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees.

Annals of Surgical Oncology

ISSN: 1068-9265 (print version), ISSN: 1534-4681 (electronic version)

Springer

Related Oncology Articles from Brightsurf:

Study reveals impact of COVID-19 on oncology staff and their work
A study presented at the NCRI Virtual Showcase reports the results of a survey of oncology staff on their management of patients, their wellbeing and whether they felt valued during the first wave of the COVID-19 pandemic.

Study of COVID-19 levels in oncology staff suggests need for more extensive testing
A study of oncology staff carried out immediately after the spring peak of the COVID-19 pandemic in the UK indicates that many had been infected with the coronavirus as they tested positive for COVID-19 antibodies.

Troubled independent oncology practices in COVID-19 era
The financial risks and challenges for independent oncology practices in the COVID-19 era and possible solutions to promote their stability and survival are discussed in this Viewpoint.

FDA support for oncology drug development during COVID-19
This Viewpoint from the U.S. Food and Drug Administration puts into context recent guidance on clinical trials during COVID-19 for oncology and shares insight regarding regulatory challenges and lessons learned.

Novel immune-oncology approach for potential cancer treatment
A research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for the potential treatment of cancer.

ModGraProDep: Artificial intelligence and probabilistic modelling in clinical oncology
Improving the prediction of survival indicators in patients with breast cancer using tools from artificial intelligence and probabilistic modelling is the aim of ModGraProDep, an innovative system presented in a study led by Ramon Clèries, lecturer at the Department of Clinical Sciences of the Faculty of Medicine and Health Sciences of the University of Barcelona and member of the Oncology Master Plan/ICO-IDIBELL.

Better outcomes, lower cost in first-ever oncology hospital at home evaluation
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology (ASCO) annual meeting.

Hippocampal avoidance during WBRT reduces risks on NRG Oncology trial
Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and patient-reported outcomes for patients with brain metastases.

Dozens of non-oncology drugs can kill cancer cells
Researchers tested approximately 4,518 drug compounds on 578 human cancer cell lines and found nearly 50 that have previously unrecognized anti-cancer activity.

10-year results of NRG Oncology/NSABP B-42 trial
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.

Read More: Oncology News and Oncology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.